Skip to main content
. 2020 Aug 25;11(9):989. doi: 10.3390/genes11090989

Table 3.

Known phosphorylation sites of mTORC1.

mTORC1 Subunit Site Phosphorylated Kinase mTORC1 Activity Reference
mTOR Thr 2446, Ser 2448 Akt Increase [206,207,208]
Ser 2448 S6K1 Increase [209]
Thr 2446 AMPK Decrease [210]
Ser 1261 ? Increase [211]
Ser 2481 mTOR Increase [212,213]
Ser 1415 IKKα Increase [214]
Ser 2159, Thr 2164 TBK1, ? Increase [215,216]
Raptor Ser 863, Ser 859 mTOR Increase [217,218]
Ser 696, Thr 706, Ser 863 ? Increase [219]
Ser 719, Ser 721, Ser 722 RSK1/2 Increase [220]
Ser 8, Ser 696, Ser 863 ERK1/2 Increase [221]
Ser 696, Thr 706, Ser 863 JNK Increase [222,223]
Ser 859 GSK3 Increase [224]
Ser 722, Ser 792 AMPK Decrease [86]
Ser 863 NLK Decrease [225]
Ser 791 PKA Decrease [159,160]
Ser 606 LATS1/2 Decrease [226]
Ser 696, Thr 706 cdc2 Increase [227,228]

? = Unknown; mTORC1 components mTOR and Raptor and the corresponding phosphorylation sites, kinase and effect on mTORC1 activity. Rac-α Ser/Thr-protein kinase (Akt also known as PKB); p70 ribosomal S6 kinase 1 (S6K1); AMP-activated protein kinase (AMPK); mammalian or mechanistic target of rapamycin (mTOR); IκB kinase α (IKKα); TANK-binding kinase 1 (TBK1); p90 ribosomal S6 kinase 1/2 (Rsk1/2); extracellular signal-related kinase 1/2 (Erk1/2); c-Jun N-terminal kinase (JNK); glycogen synthase kinase 3 (GSK3); Nemo-like kinase (NLK); protein kinase A (PKA); Large tumor suppressor kinase 1/2 (LATS1/2); cell division control 2 (cdc2).